Mehdi Abouzari

Mehdi Abouzari, MD, PhD, is an Assistant Professor in the Department of Otolaryngology at the University of California, Irvine School of Medicine. His research focuses on tinnitus mechanisms, migraine-associated vestibulocochlear disorders, and hearing loss. He has contributed to clinical trials evaluating drug combinations for tinnitus and explored the impact of SARS-CoV-2 on the inner ear. His work integrates machine learning to predict post-surgical outcomes and optimize treatment strategies.

Research Interests: Dr. Abouzari investigates pharmacological interventions for tinnitus, migraine-related auditory and vestibular symptoms, and genetic contributors to neurological conditions like autism. He also develops AI-driven tools to improve diagnostic accuracy and patient outcomes in otology and neurotology.

Key Findings: His studies highlight the role of migraine in hearing disorders, demonstrate efficacy of drug combinations like nortriptyline-topiramate, and reveal potential genetic mutations (e.g., OXTR R150S) linked to autism. He advocates for personalized medicine approaches, including tailored sound therapy and smartphone-based interventions for tinnitus management.

Grants & Collaborations: Supported by NIH grants (e.g., TL1 TR001415), his work spans translational research and clinical applications. He collaborates on projects involving cochlear implant magnet adherence and predictive analytics for thyroidectomy outcomes.